Integrated Diagnostics Holdings PLC
07 June 2021
THIS ANNOUNCEMENT INCLUDES INSIDE INFORMATION
Change of Auditor
(Cairo and London) - Integrated Diagnostics Holdings ("IDH," "the Company" or "the Group"), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan, and Nigeria, announces that it has been notified by KPMG LLP ("KPMG") that KPMG will not be seeking reappointment as auditor of the Company when their present term of office expires at the forthcoming Annual General Meeting of the Company.
The Company is also delighted to announce that PwC has indicated its willingness to be appointed as the Company's auditor, subject to the satisfactory completion of their acceptance procedures, which is expected to become effective upon agreement by shareholders at the Company's Annual General Meeting to be held on 30th June 2021.
In accordance with paragraph (9) of Article 113B of the Companies (Jersey) Law 1991, KPMG has deposited with the Company a statement setting out the reasons for not seeking reappointment. A copy of KPMG's statutory statement is available on this link and will be sent to every member of the Company and to every person entitled to receive notice of general meetings today as required under paragraph (10) of Article 113B of the Companies (Jersey) Law 1991.
The Board of Directors of IDH ("the Board") has engaged with KPMG to ensure it understands their position. The Board notes that KPMG has provided an unqualified audit opinion on the Company's FY2020 accounts and in every year of the preceding five years.
The person responsible for arranging the release of this announcement is Nancy Fahmy, Investor Relations Director at IDH.
Investor Relations Director
T: +20 (0)2 3345 5530 | M: +20 (0)12 2255 7445 | firstname.lastname@example.org